Variational AI
Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline.
$5.50M
Latest Funding
Seed
Latest Funding Stage
2025-02-20
Funding Date
$8.99M
Total Funding
15
Employees
Canada
Location
Vancouver, British Columbia
City & State
Sales-Ready Summary
Variational AI recently raised $5.5M in Seed funding and is actively hiring for AI, Machine Learning, and Software Development roles, signaling potential expansion of their AI solutions. Companies offering AI development tools, machine learning platforms, or software development services should reach out to key decision-makers in their engineering department.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Workhelix
Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Unique
Unique is an AI-driven platform transforming financial operations through agentic AI solutions. We help financial institutions streamline middle- and back-office processes, ensuring efficiency, compliance, and security at scale.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.